Act on General Product Safety
In Poland, the main product safety legislation is the Act on General Product Safety, implementing Directive 2001/95/EC on general product safety. It sets a general standard of safety that applies to products intended for consumer use, for which no product-specific requirements have been introduced in other Acts. The Act on General Product Safety sets out the obligations of persons trading on the Polish market. It is the basis for product safety inspections and product safety surveillance.
Acts Implementing the New Approach Directives
Many aspects of product safety are also covered by two acts implementing the New Approach Directives: the Act on the conformity assessment system of 2002 and the Act on conformity assessment systems and market surveillance of 2016. These Acts do not apply to all products, but only to certain categories of products – such as personal protective equipment, toys, electrical equipment, machines, electronic equipment, etc – that are subject to EU essential requirements.
Additionally, there are various product-specific laws and regulations which also implement EU directives – eg, the pharmaceutical law, the Act on safety of food and nutrition, the Act on medical devices and the Act on cosmetics.
The main regulator responsible for product safety monitoring in Poland is the President of the Office for Competition and Consumers Protection (OCCP). The OCCP is responsible, among other things, for monitoring compliance with general product safety requirements and conformity with the essential requirements introduced in the New Approach Directives. It initiates administrative proceedings on the basis of information obtained from the Trade Inspectorates, consumers or regulators of other EU member states. Product inspections are conducted by the Trade Inspectorates, which inform the OCCP about the likelihood of the lack of safety of the inspected product. If the proceedings show that a product poses a threat to consumers, the President of the OCCP may impose specific obligations on that product's manufacturer or distributor. Fines may also be imposed for not following product safety requirements or for non-conformity with the essential requirements.
Some product groups – eg, pharmaceuticals, medical devices and food products – have other sector-specific regulators. Medicinal products and medical devices are within the jurisdiction of the Office for the Registration of Medicinal Products, Medical Devices and Biocidal Products. The activities related to the product safety and market surveillance of this Office include:
Additionally, the Chief Pharmaceutical Inspector is competent in terms of the quality of medicinal products (which relates to their safety) and it can issue decisions suspending their distribution or recalling them from the market. The main regulator for food products and cosmetics is the Chief Sanitary Inspector who is responsible, inter alia, for monitoring safety of food products and cosmetics. Food products’ inspections are conducted by the Agricultural Inspection Agency (IJHARS), which, inter alia, informs the national Rapid Alert System for Food and Feed (RASFF) contact points about decisions issued when food and agri-products that are not safe.
In terms of general product safety, the subject of corrective action is covered by the Act on General Product Safety, which imposes the obligation on manufacturers to take appropriate steps to minimise potential risks posed by the product, in particular, to take steps to withdraw the product, warn consumers or recall the product from the market whenever necessary. Distributors are required not to place products onto the market which they know or, given the information in their possession and their professional experience, should have known are not safe.
Corrective action can be demanded by the President of the Office for Competition and Consumers Protection (OCCP) as a result of proceedings or a safety notification. The corrective action that the authority may order, as provided for in the above Act, are:
The corrective actions, whether ordered by the President of the OCCP or undertaken as a result of the manufacturer’s or distributor’s own decision, should be proportionate to the risk that the product poses.
In addition, for more regulated products, such as medicinal products, medical devices or food products, the product-specific legislation provides for specific obligations regarding corrective action. A different authority is involved in the case of these products. This is the Office for the Registration of Medicinal Products, Medical Devices and Biocidal Products for medicinal products and medical devices, the Chief Pharmaceutical Inspector for medicinal products (as regards suspension of distribution and recalls) and the relevant state district sanitary inspector for food product safety issues.
According to the Act on General Product Safety, the trigger for notification is learning that the product placed onto the market is unsafe. The notification obligation applies to manufacturers and distributors. The system is risk-based. The manufacturer and distributor are obliged to notify the President of the Office for Competition and Consumer Protection (OCCP) that the product is not safe forthwith, which means without undue delay. According to the OCCP’s guidelines on the timing of the notification, this should be interpreted as no longer than ten days and, if the threat is serious, within three days. Polish law provides that the notification can be made via a form. The form is not obligatory, although the notifying party is required to provide all the information required in the form to the President of the OCCP. After the notification, the OCCP posts an online notice providing information about the affected product and the corrective measures taken by the manufacturer.
If the manufacturer or distributor is represented by a third party (eg, a legal counsel), a power of attorney should be attached to the notice, along with documents proving the authorisation of the persons granting the power of attorney to represent the company.
The procedures for products which are subject to stricter surveillance, such as medicinal products, medical devices and food products, can vary and are laid down in specific regulations.
According to the Act on General Product Safety, the penalties for breaching the product safety obligations are administrative fines of up to PLN100,000 (approximately EUR22,000).
In addition, the President of the OCCP can impose a fine of up to PLN100,000 (approximately EUR22,000) for putting a product onto the market which is non-compliant with the essential requirements. This only applies to certain types of products (eg, personal protective equipment or toys).
There are examples of companies fined for placing unsafe or non-compliant products onto the market. However, the fines imposed by the President of the OCCP for a breach of the general product safety requirements have not exceeded PLN60,000 (EUR13,400) over the past year.
If the President of the OCCP issues a final decision that the product is unsafe or non-compliant, the product is entered into the register of unsafe or non-compliant products.
In some categories of products (eg, machines and aerosol products), the manufacturer or distributor may be subject to criminal liability. In such a case, the criminal sanction is a fine to which a criminal court can sentence an individual who has been found guilty. The amount is specified by the court in every case. Theoretically, the maximum amount of the fine could be PLN1,080,000 (approximately EUR254,118), although it is very unlikely that the court would impose such a high fine for a breach of the provisions in question.
A person liable for placing medical devices that are non-compliant, or food products that are unsafe, onto the market can also be subject to criminal liability.
Product liability is regulated in Poland in the Civil Code. There are two basic regimes of product liability: strict product liability and fault-based tort liability. Strict product liability in the Civil Code implements the EU Directive 85/374/EEC of 25 July 1985. Product liability claims can also arise under contract law but only if there is a contractual relationship between the claimant and the defendant.
Causes of Action
In the case of strict product liability, the causes of action are (i) damage, (ii) a defect in the product and (iii) a causal link between the damage and the defect.
Strict product liability applies to death, personal injury and damage to property normally intended for private use.
Under tort liability, causes of action are (i) an unlawful act of the defendant, (ii) the defendant’s fault, (iii) damage and (iv) a causal link between the damage and the defendant’s act. It is assumed that putting a dangerous product on the market constitutes negligence.
Under contract law, the causes of actions are (i) a breach of contract, (ii) damage and (3) a causal link between the breach of contract and the damage.
The risk-based liability regime does not require proof of fault, which is more convenient for claimants.
Under the strict liability regime, an action can be initiated against:
In the tort liability regime, an action can be initiated against anyone who caused the damage through their fault.
An action can be initiated against the other party to the contract under contract law.
According to the Polish Civil Code, a person who has suffered damage caused by a defective product can file a claim for product liability. A claim for damages (compensation for financial damage) can be inherited; a claim for compensation for pain and suffering can only be inherited if the person who suffered the damage filed the action before he or she died.
If the injured person dies as a result of the damages suffered, his or her relatives have a separate claim against the person responsible for a defective product. This claim covers medical and funeral costs. Under certain circumstances, the relatives of the deceased party can also claim their own damages (if the death of the victim caused a deterioration in their standard of living), the payment of a monthly annuity, as well as compensation for their suffering.
The Polish Civil Code foresees several limitation periods for product liability claims. First of all, in the strict product liability regime, the limitation period is three years from the day on which the injured party learned or, acting with due diligence could have learned, about the damage and the person who is obliged to remedy it; however, the claims become time-barred after ten years from the date when the product was placed onto the market in any case. Please note that Polish law differs from the Directive 85/374/EEC which provides that product liability claims shall be extinguished upon the expiry of that ten-year period.
There is also a limitation period for claims in the fault-based tort regime, which is three years from the day on which the injured party learned about the damage and the identity of the liable person. The general rule is that a claim in tort becomes time-barred after ten years from the event that caused the damage.
However, if the damage is personal injury, the limitation period is three years from the day on which the injured party learned about the damage and the identity of the liable person and it is not limited by any additional period. Therefore, claimants whose claims are time-barred in the strict liability regime sometimes decide to pursue a claim in the tort liability regime.
In addition, if the damage is a result of a crime, the statute of limitations with respect to the claim for damages is 20 years from the date when the crime was committed.
Please note that, on 9 July 2018, a new provision entered into force which provides that all limitation periods that are longer than two years end on the last day of the calendar year which means they are practically prolonged until 31 December of the given year. There are ongoing discussions over whether this applies to the limitation periods relating to tort and product liability claims. Additionally, it is unclear how these new provisions apply to tortious acts committed before 9 July 2018.
In general, under the Polish Civil Procedure Code, courts have jurisdiction if the defendant has his or her place of residence in, or is a habitual resident of, Poland.
Additionally, in tort cases, Polish courts are competent if the harmful event occurred in Poland. Pursuant to well-established CJEU jurisprudence, the harmful event occurs in a member state if either the tortious act is performed (eg, the defective product is sold), or the damage occurs (eg, the party suffers injury), there. The same rules apply to claims in strict product liability regime.
Similarly, if the claim arose from a contract which was performed in Poland, Polish courts will have jurisdiction over this claim (eg, if a defective product was delivered to Poland).
A consumer that has his or her place of residence in, or is a habitual resident of, Poland can file a statement of claim in Poland, if his or her claim arose from a contract and the consumer’s efforts to execute this contract were applied in Poland. A consumer can also file a statement of claim if the other party has its enterprise or branch in Poland and the contract with the consumer involves the operations of that enterprise or branch. Additionally, if the EU Regulation 1215/2012 applies, the consumer can always file a statement of claim in Poland if he or she is domiciled in Poland, irrespective of the other party’s registered office or domicile.
There are no mandatory pre-action procedures.
However, in the statement of claim, the plaintiff has to disclose whether the parties undertook mediation or any other method of alternative dispute resolution and, if not, what the reason was for such an omission.
There is a financial risk for the claimant if he or she does not contact the defendant before filing the statement of claim (eg, by sending a letter of claim). He or she will have to pay all the defendant’s costs related to court proceedings if that defendant gave no reason to bring a lawsuit and acknowledged the claim at the first opportunity in the court proceedings.
There is no requirement to preserve documentation or other evidence for the purpose of product liability claims.
The obligation to keep certain documents or batch samples may arise from product-specific administrative laws (eg, pharmaceutical law), but this is not strictly related to the product liability regime. The failure to satisfy the administrative obligation does not have a direct impact on civil liability, however it can impact the court’s evaluation of the defendant’s due diligence.
Additionally, the court can secure evidence before civil proceedings are initiated. This means that the court can order the production of certain documents or preservation of other evidence if there is a risk that it will be impossible or very difficult to obtain them in the future. This procedure is used, for example, to preserve explanted medical devices which formally constitute medical waste and should be disposed of appropriately by the relevant healthcare centre.
There is no general disclosure requirement under Polish law. Each party presents evidence, including documents, to support their position. However, the court may request any person, including a party to the proceedings, to produce a particular document that is in its possession, unless it contains confidential information. A party may not refuse to produce a document if the loss that the party could suffer as a result would only be the loss of the case.
If a party to the proceedings refuses to produce a document pursuant to the court’s request, the court shall assess the justification of the refusal and take the refusal into consideration while determining the relevant facts of the case. If an individual that is not a party to the proceedings refuses to produce the requested document without valid justification, it can be punished with a fine of up to PLN3,000 (approximately EUR675).
Expert evidence is required under Polish law whenever there is a need for expertise in any scientific or technical area. It can be provided by an individual expert, a team of experts with various areas of expertise, or an academic institute (eg, a university faculty).
A court expert can only be appointed by the court. The parties are allowed to suggest a particular expert to be appointed as a court expert and propose a list of questions to the expert, although the court in not bound by those suggestions. Private expert opinions may be submitted by the parties, although they have purely persuasive value for the court expert and the court cannot rely on them when issuing its judgment.
Expert opinions are generally prepared in writing; after submitting his or her opinion, the expert may be examined by the court and the parties at a hearing.
Generally, the party that claims a certain fact to be true must prove it. This means that the claimant has the burden of proof with regard to all the facts required for the cause of the action. The defendant must prove all the facts that are required for his or her defence (for the facts that need to be proved in product liability cases, see 2.1 Product Liability Causes of Actions and Sources of Law; for potential defences, see 2.12 Defences to Product Liability Claims).
This burden of proof may be shifted from time to time by the court. The court is allowed to accept prima facie evidence or consider certain facts as having been proved if they are a logical consequence of a fact already established.
Product liability cases are brought in civil courts. They can be filed in a district or regional court; this depends on the value of the claim. If the value of the claim is more than PLN75,000 (approximately EUR17,000), the claim should be brought in the regional court. The cases are decided on by a professional judge (no jury) in the first instance and three professional judges in the second instance.
Polish law does not foresee any upper threshold for the award of damages. The damages depend on the actual losses of the winning claimant. The compensation for pain and suffering depends on multiple factors, most of all on the court’s assessment of the type and magnitude of the winning claimant’s suffering.
It is worth noting that Polish courts do not award compensation at levels that are as high as are awarded in Western Europe or the USA, although a significant increase can be observed in the sums adjudicated.
There are no special proceedings regarding product liability cases. They are heard in general civil proceedings, regardless of whether the basis of the claim is strict product liability, tort or contract.
The party that loses the case before the court of first instance is allowed to file an appeal. The losing party petitions the court to be served with the judgment with the reasons. After the judgment with the reasons is served, the party has two weeks to file an appeal.
The party may challenge the factual findings of the court of first instance, as well as a breach of substantive law or the rules of procedure.
The court of second instance may confirm, revoke and remand, or revise the judgment of the court of first instance.
The party may file a cassation complaint with the Supreme Court against the judgment of the court of second instance. However, this is limited, as the party may only challenge issues of substantive law or procedural rules, if their breach has had a significant impact on the outcome of the case. The Supreme Court only hears a cassation complaint if particular criteria are met (eg, the value of the claim is not less than PLN50,000).
If a cassation complaint is not allowed in the case, the party may seek to declare a final judgment inconsistent with the law. However, such a declaration does not revise the final judgment but allows the claimant to claim compensation from the State if damage was caused to him or her by that defective judgment.
According to the Polish Civil Code, the following defences are available under the strict liability regime:
In addition, if the manufacturer only provided a component of the product, he or she has a defence if the damage was caused solely by the defective design or instructions given by the producer.
Under tort liability, the defendant can defend him or herself by proving that there was no fault on his or her part.
In both regimes, the defendant may prove that there was no causal relationship between the defect and the damage if the damage was caused entirely through the claimant’s or a third party’s fault. The defendant could also argue that the injured person or third party contributed to the damage, which would have an influence on the level of damages awarded to the claimant.
In terms of the strict liability regime, the fact that the product is compliant with the regulatory requirements alone cannot exempt the defendant from liability. If the examination of the product reveals that it has a defect, it is irrelevant whether the product adhered to the regulatory requirements. Such a defence is only available when the defects in the products are due to compliance with the provisions of the law.
However, in the case of the tort liability regime, adherence to the regulatory requirements could be useful for arguing that the manufacturer was not negligent and that they had the right to believe that the product was safe.
In Poland, the rules regarding the payment of litigation costs allow the winning party to recover the costs of the litigation. As a rule, the court orders the losing party to cover all the necessary costs of the successful party. The successful party can recover court fees; for instance, if the claimant wins, he or she can recover the court fee paid when filing the claim. The successful party can also recover the costs of an advance payment for expert opinions.
The winning party can be granted recovery of the costs related to legal representation, although the recovery only applies to some extent. The statutory recoverable legal costs are calculated according to the regulation on legal fees. These amounts are rather low. They usually do not cover the full amount of actual costs.
Third-party litigation funding is legal under Polish law, but can be described as almost non-existent in practice.
No win no fee arrangements are permissible by law in Poland, but are prohibited under the code of ethics of attorney-at-law practice. A contingency fee understood as a win-fee can be arranged but only as an additional payment. The attorney must be paid his or her basic fee regardless of the outcome of the proceedings.
There is also a system of public funding, which is available for parties that cannot afford the cost of the proceedings due to their financial standing. They can be exempt from court fees in full or in part and they can be granted a legal counsel within the framework of legal aid.
A group action is available under Polish law, but is not very popular. Product liability claims may be pursued in this type of action. The group action is always heard by the regional court as the court of first instance.
The Polish system uses the opt-in model. At least ten people are required to select a representative to act on their behalf. The representative can be a member of the group or a district consumers’ ombudsman. As regards claims relating to personal injuries, the group may only seek to establish the defendant’s liability in general (and then individual members will follow this up with individual claims of a given amount in separate proceedings). For other type of claims, it is possible to seek compensation in the form of monetary claims in equal amounts in groups of at least 2 people. New claimants can join the group once the action is filed until the court closes the initial stage of the proceedings.
The defendant may demand that the claimants pay a security deposit for its legal fees if the claim fails.
Co-ordinated proceedings, in the form of formal joinder of parties, are also admissible under Polish law. The conditions are that:
Supreme Court Judgment of 29 May 2019, III CSK 209/17
The claimant was injured by automatic doors in a supermarket. The doors had a defect because they could not detect a person standing between them if the person did not move.
The claimant filed an action against the partners of the partnership who installed the door and were responsible for its maintenance. The partners’ defence was that they did not manufacture the defective doors and were therefore not liable. The courts of first and second instance dismissed the claim.
The Supreme Court revoked and remanded the case to the regional court. The Supreme Court held that, according to the Polish Civil Code, when determining whether the injured party knew that the person who sold the defective product was not its manufacturer, the court has to take the average consumer’s knowledge into consideration. If the injured party files a claim against the person who sold the defective product, even if the injured party does not specify that it is seeking liability in a strict liability regime, the seller has to inform the injured party about the producer or importer if it wants to be exempted from liability.
Judgment of the Appellate Court in Białystok of 29 April 2016, I ACa 20/16
The plaintiff was the lessee of a sawmill with a sharpener. The defendant was the lessor of that sawmill. Under the lease contract, the defendant was the owner of the facility, but the plaintiff was responsible for buying the necessary equipment to operate the sawmill, including saws. The sawmill was not operating properly, either because of a defect or the plaintiff’s incorrect choice of saws. The plaintiff claimed that the sawmill should be considered a hazardous product because it was not operating property and did not have a CE certificate and therefore the defendant should be liable under the strict liability regime.
The court of the first instance dismissed the claim and the appellate court upheld this judgment. Specifically, the appellate court rejected the plaintiff’s argument that the lack of CE certificate automatically meant that the product was hazardous. The court held that, especially if a product has never undergone an examination, the conclusion that it does not meet the required safety standards solely because it lacks a CE certificate, is premature. On the other hand, the court mentioned that the situation may have been different had the product been examined for a CE certificate and failed.
Supreme Court Judgment of 2 October 2015, II CSK 816/14
The claimant was injured by a phone charger that scalded her skin during use.
The claimant filed an action against two entrepreneurs, from whom she claimed to have bought the charger. Later, the company that allegedly imported the phone charger to the EU joined the proceedings as co-defendant. The courts of first and second instance dismissed the claim, because the plaintiff failed to prove that she bought the phone charger from the sued entrepreneurs and that the sued company imported the phone charger to the EU.
The Supreme Court revoked and remanded the case against the company that imported the phone charger. The Supreme Court held that, although the claimant has to prove that a particular entity imported the product to the EU, the burden of proof then switches to the defendant. The defendant has to prove that it did not place the product onto the market. The Supreme Court also pointed out that the court might accept the prima facie evidence that the particular entity placed the product onto the market.
Judgment of the Appellate Court in Kraków of 9 June 2015, I ACa 1469/14
The plaintiff was injured when, during cryotherapy treatment, she accidentally lost her balance and pushed the cabin door which resulted in the door opening and her falling on her back from around 50cm. This incident led to a serious fracture of her tibia bone, which resulted in a number of painful operations. The defendant was the company that manufactured the cabin. It claimed that the cabin had no defect as it had all the necessary safety certificates. Additionally, it said that there is no obligation to warn users about the possibility of falling out of the cabin in the IFU, as such an incident is obvious to any reasonable person.
The court of the first instance dismissed the claim. The appellate court amended this judgment and ruled against the defendant. The appellate court emphasised that the manufacturer did not warn the purchaser (in this case – the sanatorium, in which the plaintiff had her cryotherapy treatment) about the door potentially opening when a patient loses his or her balance and pushes the door with his or her full weight. This led to a lack of appropriate warnings given by the sanatorium staff to the patient. Additionally, such an incident could have been predicted, as the nitrogen vapours coming from the cryotherapy cabin can lead to the patient becoming dizzy or even unconscious. The appellate court held that the safety certificates were irrelevant in this case, as – during the examination before issuing them – a potential fall from the cabin had not been analysed. Therefore, if the producer failed to warn the purchaser about the user potentially falling out from the cabin, the conclusion should be that he or she did not fulfil his information duty and the product should be considered hazardous.
A major legislative change that impacts product liability litigation is the recent amendment to the Polish Civil Procedure Code, which came into force on 7 November 2019. The most important changes include:
The new procedural rules are aimed at speeding up the civil proceedings and making them more efficient. They introduce more stringent rules as to the form and timing of the presentation of allegations and evidence, which shift a greater burden onto the parties and their legal counsel.
There has also been an increase in recent years in the presence of companies that assist people to pursue compensation claims, primarily against insurers. These companies usually do not employ qualified lawyers and often rely on a heavy load in claims without an in-depth analysis of each case.
There is no particular trend in product safety with regard to specific products, which are mainly subject to the inspections of the Trade Inspectorate. In previous years, the Trade Inspectorate has conducted many inspections of different types of products, such as toys, children’s bicycles and child bike seats, phone chargers, heatproof dishes, winter sports equipment, lamps and food. The most recent inspection applied to the safety of toys. The inspection showed irregularities in the case of 26.7% of all inspected toys, most of which were of a formal nature.
As for product safety issues, there is a stable trend in the most common types of products with regard to which the manufacturers and distributors make safety notifications to the President of the Office for Competition and Consumer Protection, these are mainly cars and motorcycles.
No amendments are currently being proposed to the legislation and no new legislation is planned for product liability and product safety in Poland. Polish legislation reflects the law and guidelines that are applicable in the EU, so any amendments to EU legislation would be respectively introduced in Poland. The only draft law currently related to products is an act introducing the objectives of the EU Regulation 2019/515 on the mutual recognition of goods lawfully marketed in another member state and repealing Regulation (EC) No 764/2008. Please refer to 3.1 Trends in Product Liability and Product Safety Policy in the EU chapter of this Guide for further discussion of EU Regulation 2019/515.
COVID-19 and the Product Liability and Product Safety Regime
Legislation passed to combat COVID-19 in Poland has not brought any relevant changes to the substantive rules of the product liability regime.
However, the COVID-19 epidemic has had a huge impact on the courts and civil proceedings. The COVID-19 legislation in Poland suspended deadlines in court proceedings from 31 March to 24 May 2020. No public hearings were held during that time, so all the pending cases were effectively put on hold.
During the epidemic, and for one year thereafter, public hearings in civil court proceedings are to be conducted online unless a standard hearing with traditional attendance of the parties does not pose an excessive threat to the health of the people participating in them. No technical requirements have been set and courts are not prepared to conduct them.
The COVID-19 legislation extended the possibility of hearing cases in camera. During the epidemic, and for one year thereafter, a case may be considered in camera, if the following conditions are satisfied:
If the proceedings on taking evidence in the case have been conducted in full, the court may close the trial and issue a decision at a session held in camera, after having previously collected the positions of the parties or participants in writing.
The ability to consider cases during a session in camera by the court of second instance has also been extended.
There were exceptions to the suspension of the deadlines in court proceedings, but these were mostly related to criminal and family law. In terms of general civil proceedings, only the extraordinary procedure of securing evidence (eg, hearing a witness before a trial due to the threat that he or she may not be able to testify later) was considered as “urgent” and could have been conducted during the suspensions of the deadlines.
From the product safety point of view, the most important area targeted for special exemptions in connection with the COVID-19 pandemic was the market for medical devices and personal protective equipment. In connection with Commission Recommendation (EU) 2020/403 of 13 March 2020 on conformity assessment and market surveillance procedures within the context of the COVID-19 threat, the Polish government introduced a temporary solution, which allowed the Ministry of Health to buy personal protective equipment without a CE mark, before the conformity assessment of such products was completed. Additionally, upon introducing these exemptions, the Ministry of Health became entitled to buy medical devices and personal protective equipment that were authorised in different countries outside the EU.
Supply Chain Issues
Since the beginning of the pandemic, there has been an increase in demand for medical devices and personal protective equipment such as masks, gloves and disinfectants. Many companies from various industries started producing and selling such products. Unfortunately, the products were not always of good quality and some did not conform to EU requirements.
Projected Impact of COVID-19
Increased interest in selling pandemic-related products has sometimes resulted in products being placed onto the market that do not meet essential EU requirements. This phenomenon may result in product liability claims in the future. As such products were often bought from entities from outside the EU, the most exposed persons are importers who cannot free themselves from civil liability.
In addition, this phenomenon may also result in an increased number of safety notifications and increased activity of the President of the OCCP.